Home > Insider Trading > Filing (0001209191-23-052547)

Filing Details

Accession Number:: 0001209191-23-052547
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-10-10 17:02:45
Reporting Period:: 2023-10-05

Accepted Time:: 2023-10-10 17:02:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1801777	Applied Molecular Transport Inc.	AMTI	Pharmaceutical Preparations (2834)	814481426

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1813286	Ph.d. Tahir Mahmood	Amti C/O Corporation Trust Company, Trust Center, 1209 Orange St Wilmington DE 19801		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-10-05	886,111	$0.00	955,500	No	4	A	Direct
Common Stock	Disposition	2023-10-06	184,442	$0.16	771,058	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,208,307	Indirect	By Living Trust
Common Stock	391,693	Indirect	By Irrevocable Trust

Footnotes

The reported shares are represented by restricted stock units, or RSUs. 443,055 RSUs vested on the date that was ten trading days following the signing of the Agreement and Plan of Merger dated as of September 21, 2023, among Cyclo Therapeutics, Inc., a Nevada corporation, Cameo Merger Sub, Inc., a Delaware corporation and the Issuer (the "Merger Agreement"). The remaining 443,056 RSUs vest as to 50% on the date that is ten trading days following the filing of the proxy/prospectus relating to stockholder approval of the merger contemplated by the Merger Agreement (the "Form S-4") and 50% on the date the Form S-4 is declared effective by the SEC.
Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
A portion of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
These shares are held directly by the Mahmood-Shamsi Living Trust Agreement for which the Reporting Person and spouse serve as co-trustees and over which shares the Reporting Person and his spouse hold voting and dispositive power.
These shares are held directly by The Mahmood 2017 Irrevocable Trust for which the Reporting Person serves as trustee and over which shares the Reporting Person hold voting and dispositive power.